Tuberculosis

Tuberculosis (TB) is a bacterial infection caused by a germ called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes or talks. If you think you have been exposed, you should go to your doctor for tests as soon as possible. You are more likely to get TB if you have a weak immune system.

What is Tuberculosis?

Tuberculosis (TB) is a dreaded bacterial infection. It has been known to mankind since ancient ages. It was commonly called “consumption” at the turn of the last century because of the way the disease seemed to “consume” the individual it affected.

How Has The COVID-19 Pandemic Affected Tuberculosis Eradication?

Tuberculosis Causes

Tuberculosis Diagnosis

Tuberculosis Prevention

Tuberculosis Screening

Tuberculosis Treatment

Tuberculosis Prognosis

History of Tuberculosis

Tuberculosis in Animals

Tuberculosis Transmission

New tuberculosis technologies: importance of access in the private health sector

See more featured articles »

What is the END TB Strategy?

Latest Tuberculosis News and Research

Powerful imaging tool creates 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions

Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast, reveals the microscopic anatomy of biological structures. But that magnification comes at a cost -; histology shows only two-dimensional shapes because it studies small, flat slices of stained tissue.

29 Nov 2022

How SARS-CoV-2 immune responses vary by population due to environmental and genetic factors

Researchers investigate the genetic, immunological, and evolutionary factors that determine the vast variability observed in clinical manifestations of COVID-19.

28 Nov 2022

How national programs leveraged PEPFAR-supported laboratory resources for SARS-CoV-2 testing during the COVID-19 pandemic

Researchers described ways in which national-level programs leveraged PEPFAR [president’s emergency plan for acquired immunodeficiency syndrome (AIDS) relief]-aided laboratory-based resources for SARS-CoV-2 testing during COVID-19.

24 Nov 2022

New EULAR recommendations for screening and treating infections in AIIRD patients

It is already known that people who are immunocompromised are more prone to infections. Chronic and opportunistic infections are often found in people with an AIIRD, and may be linked to some of the immunosuppressive and immunomodulatory treatments used to treat these rheumatic diseases.

22 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

Mistrust and polarization steer rural governments to reject federal public health funding

When Elko County commissioners rejected a $500,000 grant from the Centers for Disease Control and Prevention that could have helped the county create a health department or health district, Kayla Hopkins pleaded with them to reconsider.

20 Nov 2022

Experts highlight the need to study and develop treatments for fungal infections

Fungi in the soil cause a significant number of serious lung infections in 48 out of 50 states and the District of Columbia, including many areas long thought to be free of deadly environmental fungi, according to a study by researchers at Washington University School of Medicine in St. Louis.

17 Nov 2022

Study reveals neglected or late TB diagnoses related to COVID-19

In a recent study published in the journal BMJ Medicine, researchers modeled changing patterns in sex- and age-stratified new and relapse tuberculosis (TB) case notifications reported to the World Health Organization (WHO) for 45 nations with high TB, TB/human immunodeficiency virus (HIV) and multidrug-resistant TB (MDR-TB) burden between 2013 and 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

16 Nov 2022

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.

16 Nov 2022

Certain TB correlates of protection linked with the likelihood of becoming infected with Mycobacterium tuberculosis

Researchers from the University of Oxford have today reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB.

15 Nov 2022

Oral deucravacitinib shows promise in patients with active lupus

Tyrosine kinases are enzymes that play central roles in signaling by cytokines involved in the pathogenesis of autoimmune diseases, including lupus.

14 Nov 2022

New UK aid will help fight AIDS, tuberculosis, and malaria

New UK aid support to the Global Fund will help fight AIDS, tuberculosis, and malaria around the world, Minister for Development Andrew Mitchell announced today (Monday 14 November).

14 Nov 2022

How lessons from the HIV epidemic can help combat COVID-19

Researchers revisit lessons learned from the HIV pandemic in response to COVID-19.

13 Nov 2022

Proteomics approach helps identify protein signatures that can improve detection of prediabetes

Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of isolated impaired glucose tolerance, a form of prediabetes.

10 Nov 2022

Irish Government funds tripartite collaboration to explore the role of vitamin D in bovine TB

The Irish Government has funded a tripartite collaboration to investigate the role of vitamin D in bovine tuberculosis (bTB).

10 Nov 2022

Pioneering artificial intelligence could ease winter pressures on hospitals

Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – could ease winter pressures on hospitals, University of the West of Scotland researchers believe.

7 Nov 2022

Post-‘Roe,’ contraceptive failures carry bigger stakes

Birth control options have improved over the decades. Oral contraceptives are now safer, with fewer side effects. Intrauterine devices can prevent pregnancy 99.6% of the time. But no prescription drug or medical device works flawlessly, and people's use of contraception is inexact.

7 Nov 2022

New test detects low levels of pathogenic amphiphilic endotoxins

Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a fast and cost-effective method to test liquids for a ubiquitous family of chemical compounds known as amphiphiles, which are used to detect diseases such as early-stage tuberculosis and cancer as well as to detect toxins in drugs, food, medical devices and water supplies.

3 Nov 2022

New insights into the dynamic inner world of the human immune system

As researchers glean new insights into the dynamic inner world of the human immune system, it has become increasingly clear that mitochondria are critical regulators of how our bodies respond to disease.

3 Nov 2022

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

Tuberculosis

Overview

How Has The COVID-19 Pandemic Affected Tuberculosis Eradication?

Tuberculosis Causes

Tuberculosis Diagnosis

Feature Articles

Tuberculosis Prevention

Tuberculosis Screening

Tuberculosis Treatment

Tuberculosis Prognosis

History of Tuberculosis

Tuberculosis in Animals

Tuberculosis Transmission

New tuberculosis technologies: importance of access in the private health sector

What is the END TB Strategy?

Latest Tuberculosis News and Research

Powerful imaging tool creates 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions

How SARS-CoV-2 immune responses vary by population due to environmental and genetic factors

How national programs leveraged PEPFAR-supported laboratory resources for SARS-CoV-2 testing during the COVID-19 pandemic

New EULAR recommendations for screening and treating infections in AIIRD patients

Exploring antibiotic resistance in the EU

Mistrust and polarization steer rural governments to reject federal public health funding

Experts highlight the need to study and develop treatments for fungal infections

Study reveals neglected or late TB diagnoses related to COVID-19

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Certain TB correlates of protection linked with the likelihood of becoming infected with Mycobacterium tuberculosis

Oral deucravacitinib shows promise in patients with active lupus

New UK aid will help fight AIDS, tuberculosis, and malaria

How lessons from the HIV epidemic can help combat COVID-19

Proteomics approach helps identify protein signatures that can improve detection of prediabetes

Irish Government funds tripartite collaboration to explore the role of vitamin D in bovine TB

Pioneering artificial intelligence could ease winter pressures on hospitals

Post-‘Roe,’ contraceptive failures carry bigger stakes

New test detects low levels of pathogenic amphiphilic endotoxins

New insights into the dynamic inner world of the human immune system

COVID-19 pandemic increased deaths and disease caused by tuberculosis

Miracles Start in the Lab: the quest to find a vaccine to cure AIDS

Pioneering new medical imaging solutions

Pioneering new medical imaging solutions

Drug Discovery eBook

Tuberculosis

Overview

Feature Articles

Tuberculosis Prevention

Tuberculosis Screening

Tuberculosis Treatment

Tuberculosis Prognosis

History of Tuberculosis

Tuberculosis in Animals

Tuberculosis Transmission

New tuberculosis technologies: importance of access in the private health sector

What is the END TB Strategy?

Latest Tuberculosis News and Research

Miracles Start in the Lab: the quest to find a vaccine to cure AIDS

Pioneering new medical imaging solutions

Pioneering new medical imaging solutions

Drug Discovery eBook

Newsletters you may be interested in